HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


IFF bows out on H&R

This article was originally published in The Rose Sheet

Executive Summary

Fragrance and flavors supplier is not likely to make formal bid for Bayer's Harrmann & Reimer fragrance and flavors division and does not "anticipate any acquisition activity in the short-term," CEO Richard Goldstein says during the company's annual meeting May 7. "We did look at H&R, and at the moment, my view is that we've got enough on our plate," exec notes. Givaudan and Dutch chemical supply company Degussa are among those interested in acquiring the business; sale is expected to be complete by summer (1"The Rose Sheet" April 22, 2002, In Brief)...

You may also be interested in...

Haarmann & Reimer sale

As many as seven or eight parties are bidding for Harrmann & Reimer fragrance & flavors division, Bayer says. German specialty chemicals group Degussa, Swiss fragrance supplier Givaudan and institutional investors are among those who have entered non-binding bids for the business, company reports. Bayer, which is selling H&R to focus on its chemicals business, is on track to complete sale by summer ( 1"The Rose Sheet" March 18, 2002, In Brief)...

On CRN Challenge, Nexus Formulas Gets Lesson On Supporting Ad Claims For Supplements

So full of errors were the firm's online ads for its Plavinol supplement, the National Advertising Division noted support for some claims contained "many of the same flaws" as others. The prevalence of problems prompted NAD to go its "scope of review" and note unclear instructions on Plavinol labels.

FDA’s Cannabidiol Crackdown: What Do Warning Letters Say About CBD In Cosmetics?

Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts